i-trans-Dichlorodiamineplatinum(II) CAS:14913-33-8
Kwikhemistri yezonyango, i-trans-Dichlorodiamineplatinum (II) yaziwa kakhulu ngokusetyenziswa kwayo njengeyeza lokulwa nomhlaza. Liyinxalenye ebalulekileyo yeyeza le-chemotherapy i-cisplatin, elisetyenziselwa ukunyanga iintlobo ezahlukeneyo zomhlaza, kubandakanya umhlaza wamasende, wesibeleko, kunye nomhlaza wesinyi. Amandla ayo okubophelela kwi-DNA nokuphazamisa ukwahlukana kweeseli kuyenza ibe sisixhobo esibalulekileyo kunyango lomhlaza. Kwi-catalysis, i-trans-Dichlorodiamineplatinum (II) iye yahlolwa ngenxa yezicelo zayo kwi-organic synthesis. Isetyenziswe njenge-catalyst kwiimpendulo ezahlukeneyo zeekhemikhali, kubandakanya ukwakheka kweebhondi ze-carbon-carbon, ukusebenza kwee-molecules ze-organic, kunye nokuhlanganiswa kwee-compounds ezintsonkothileyo ze-organic. Umsebenzi wayo ophezulu we-catalytic kunye nokukhetha kwayo kuyenza ibe yi-catalyst ebalulekileyo ekuphuhlisweni kweenkqubo zeekhemikhali ezisebenzayo nezizinzileyo. Kwisayensi yezinto, i-trans-Dichlorodiamineplatinum (II) iye yaphandwa ngenxa yokusetyenziswa kwayo okunokwenzeka ekuphuhlisweni kwezinto eziqulethe iplatinum kunye nezicelo kwi-catalysis, sensing, kunye nezixhobo ze-elektroniki. Imizamo yophando igxile ekusebenziseni le compound ukuphuhlisa izinto ezisekelwe kwiplatinum ezifana ne-nanoparticles, iifilimu ezincinci, kunye neepolymers zokudibanisa kwizicelo ezahlukeneyo zobuchwepheshe. Ngamafutshane, i-trans-Dichlorodiamineplatinum (II) ibonisa ukusetyenziswa okunokwenzeka kwikhemistri yamayeza, i-catalysis, kunye nesayensi yezinto. Indawo yayo yokudibanisa eyahlukileyo kunye nokusebenza kwayo kuyenza ibe yinto enomdla kuphuhliso lonyango olutsha lomhlaza, iinkqubo zokulungisa, kunye nezinto ezisebenzayo.
| Ukwakhiwa | I-Cl2H4N2Pt |
| Uvavanyo | 99% |
| Inkangeleko | Amandla amhlophe |
| Inombolo ye-CAS | 14913-33-8 |
| Ukupakisha | Encinci kwaye ininzi |
| Beka ubomi kwishelufa | iminyaka eyi-2 |
| Indawo yokugcina izinto | Gcina kwindawo epholileyo neyomileyo |
| Isiqinisekiso | I-ISO. |








